MedPage Today on MSN6d
TYK2 Inhibitor Scores Two Wins Outside Plaque PsoriasisThe TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback